| Ticker Details |
|
bioAffinity Technologies, Inc.
|
| IPO Date: |
September 1, 2022 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$7.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.10 | 5.49%
|
| Avg Daily Range (30 D): |
$0.10 | 4.25%
|
| Avg Daily Range (90 D): |
$0.16 | 7.03%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.48M |
| Avg Daily Volume (30 D): |
.33M |
| Avg Daily Volume (90 D): |
6.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
339 |
| Avg Trade Size (Sh.) (30 D): |
167 |
| Avg Trade Size (Sh.) (90 D): |
240 |
| Institutional Trades |
| Total Institutional Trades: |
13 |
| Avg Institutional Trade: |
$1.29M |
| Avg Institutional Trade (30 D): |
$1.27M |
| Avg Institutional Trade (90 D): |
$1.27M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-6.83
|
$-.81
|
$-1.11
|
|
Diluted EPS
|
$-6.83
|
$-.81
|
$-1.11
|
|
Revenue
|
$5.66M
|
$1.35M
|
$1.59M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-15.88M
|
$-3.63M
|
$-3.14M
|
|
Operating Income / Loss
|
$-11.56M
|
$-3.62M
|
$-3.14M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$2.65M
|
$-3.35M
|
$-1.22M
|
|
PE Ratio
|
|
|
|
|
|
|